scholarly journals Coding potential of laboratory and clinical strains of human cytomegalovirus

2003 ◽  
Vol 100 (25) ◽  
pp. 14976-14981 ◽  
Author(s):  
E. Murphy ◽  
D. Yu ◽  
J. Grimwood ◽  
J. Schmutz ◽  
M. Dickson ◽  
...  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Aroni Chatterjee ◽  
Sumit Mukherjee ◽  
Biswanath Basu ◽  
Debsopan Roy ◽  
Rivu Basu ◽  
...  

Abstract Human Cytomegalovirus has been implicated as a probable cause for the development of hepatic cholestasis among neonates. Our study tried to ascertain the exact demographic, biochemical and immunological markers to differentially diagnose patients with HCMV associated intrahepatic and extrahepatic cholestasis and also decipher the phylogenetic variability among the viral strains infecting the two groups. A total of 110 neonates collected over a span of 2 years were selected for the study classified into four different groups based on the presence of hepatic cholestasis and active HCMV infection. Our analysis predicted that total Cholesterol, GGT, ALP and TNFα were the only significant biological markers with exact cut-off scores, capable of distinguishing between HCMV associated intrahepatic and extrahepatic cholestasis. We confirmed that in patients belonging to both of these groups, the inflammasome is activated and the extent of this activation is more or less same except for the initial activators NLRP3 and AIM2 respectively. When we performed two separate phylogenetic analyses with HCMV gM and gN gene sequences, we found that in both cases the sequences from the IHC and EHC groups formed almost separate phylogenetic clusters. Our study has shown that the HCMV clinical strains infecting at intrahepatic and extrahepatic sites are phylogenetically segregated as distinct clusters. These two separate groups show different physiological as well as immunological modulations while infecting a similar host.


2010 ◽  
Vol 35 (3) ◽  
pp. 365-370 ◽  
Author(s):  
Zhengrong Sun ◽  
Gaowei Ren ◽  
Yanping Ma ◽  
Ning Wang ◽  
Yaohua Ji ◽  
...  

2009 ◽  
Vol 24 (2) ◽  
pp. 107-111 ◽  
Author(s):  
Ying Qi ◽  
Rong He ◽  
Yan-ping Ma ◽  
Zheng-rong Sun ◽  
Yao-hua Ji ◽  
...  

2007 ◽  
Vol 32 (S2) ◽  
pp. 1111-1118 ◽  
Author(s):  
Zhengrong Sun ◽  
Ying Lu ◽  
Qiang Ruan ◽  
Yaohua Ji ◽  
Rong He ◽  
...  

2004 ◽  
Vol 85 (5) ◽  
pp. 1301-1312 ◽  
Author(s):  
Aidan Dolan ◽  
Charles Cunningham ◽  
Ralph D. Hector ◽  
Aycan F. Hassan-Walker ◽  
Lydia Lee ◽  
...  

The genetic content of wild-type human cytomegalovirus was investigated by sequencing the 235 645 bp genome of a low passage strain (Merlin). Substantial regions of the genome (genes RL1–UL11, UL105–UL112 and UL120–UL150) were also sequenced in several other strains, including two that had not been passaged in cell culture. Comparative analyses, which employed the published genome sequence of a high passage strain (AD169), indicated that Merlin accurately reflects the wild-type complement of 165 genes, containing no obvious mutations other than a single nucleotide substitution that truncates gene UL128. A sizeable subset of genes exhibits unusually high variation between strains, and comprises many, but not all, of those that encode proteins known or predicted to be secreted or membrane-associated. In contrast to unpassaged strains, all of the passaged strains analysed have visibly disabling mutations in one or both of two groups of genes that may influence cell tropism. One comprises UL128, UL130 and UL131A, which putatively encode secreted proteins, and the other contains RL5A, RL13 and UL9, which are members of the RL11 glycoprotein gene family. The case in support of a lack of protein-coding potential in the region between UL105 and UL111A was also strengthened.


2010 ◽  
Vol 84 (11) ◽  
pp. 5594-5604 ◽  
Author(s):  
Ryan T. Saffert ◽  
Rhiannon R. Penkert ◽  
Robert F. Kalejta

ABSTRACT Human cytomegalovirus (HCMV) persists for the life of its host by establishing a latent infection. The identification of viral and cellular determinants of latency is the first step toward developing antiviral treatments that target and might clear or control the reservoir of latent virus. HCMV latency is established in CD34+ cells when expression of viral immediate early (IE) proteins that initiate lytic infection is silenced. Viral IE gene expression during lytic infection is controlled by a cellular intrinsic immune defense mediated by promyelocytic leukemia nuclear body (PML-NB) proteins such as Daxx and histone deacetylases (HDACs). This defense is inactivated at the start of lytic infection by the HCMV virion tegument protein pp71, which upon viral entry traffics to the nucleus and induces Daxx degradation. Here we show that a similar defense is present, active, and not neutralized during experimental latency in CD34+ cells infected in vitro because tegument-delivered pp71 remains in the cytoplasm. Artificial inactivation of this defense by HDAC inhibition or Daxx knockdown rescues viral IE gene expression upon infection of CD34+ cells with a laboratory-adapted viral strain but not with clinical strains. Interestingly, coinfection of CD34+ cells with clinical viral strains blocked the ability of an HDAC inhibitor to activate IE1 and early protein expression during infection with a laboratory-adapted strain. This suggests that in addition to the intrinsic defense, HCMV clinical strains contribute an HDAC-independent, trans-acting dominant means of control over viral gene expression during the early stages of experimental HCMV latency modeled in vitro in CD34+ cells.


2003 ◽  
Vol 100 (23) ◽  
pp. 13585-13590 ◽  
Author(s):  
E. Murphy ◽  
I. Rigoutsos ◽  
T. Shibuya ◽  
T. E. Shenk

2002 ◽  
Vol 54 (2) ◽  
pp. 121-127 ◽  
Author(s):  
Céline Nicolazzi ◽  
Véronique Venard ◽  
Alain Le Faou ◽  
Chantal Finance

2009 ◽  
Vol 8 (3) ◽  
pp. 1191-1201 ◽  
Author(s):  
Z.-R. Sun ◽  
Y.-H. Ji ◽  
Q. Ruan ◽  
R. He ◽  
Y.-P. Ma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document